
Kathryn Flynn, PhD
Professor
Locations
- Department of Medicine
Division of Hematology and Oncology
Biography
Dr. Kathryn Flynn is a Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology. She is also the Senior Scientific Director for Patient-Reported Outcomes in the Center for International Blood and Marrow Transplant Research (CIBMTR). She was trained in sociology (BA, MS) and population health sciences (PhD).
Leadership Positions
- Senior Scientific Director for Patient-Reported Outcomes Center for International Blood and Marrow Transplant Research
Research Interests
Dr. Flynn’s research focuses on the measure development and analysis of patient-reported outcomes as well as mixed methods approaches to understanding and improving patient-provider communication and patient decision making. She was a co-investigator in the PROMIS Network – NIH Roadmap initiative to standardize patient-reported outcomes measurement across diseases. She co-led development of the PROMIS Sexual Function and Satisfaction measure. She currently co-leads an NICHD R21 as well as a 14-site NCI-funded R01 examining clinical and patient-reported outcomes among patients with chronic myeloid leukemia who discontinue targeted therapies.
Publications
-
(Atallah E, Schiffer CA, Radich JP, Weinfurt KP, Zhang MJ, Pinilla-Ibarz J, Kota V, Larson RA, Moore JO, Mauro MJ, Deininger MWN, Thompson JE, Oehler VG, Wadleigh M, Shah NP, Ritchie EK, Silver RT, Cortes J, Lin L, Visotcky A, Baim A, Harrell J, Helton B, Horowitz M, Flynn KE.) JAMA Oncol. 2021 Jan 01;7(1):42-50 PMID: 33180106 PMCID: PMC7662490 SCOPUS ID: 2-s2.0-85096163350 11/13/2020
-
(Agochukwu-Mmonu N, Wiseman JB, Smith AR, Helmuth ME, Sarma AV, Cameron AP, Amundsen CL, Flynn KE, Cella D, Weinfurt KP, Kirkali Z, Clemens JQ.) Neurourol Urodyn. 2020 11;39(8):2161-2170 PMID: 32761962 SCOPUS ID: 2-s2.0-85089030088 08/08/2020
-
(Holt JM, Cusatis R, Winn A, Asan O, Spanbauer C, Williams JS, Flynn KE, Somai M, Laud P, Crotty BH.) JMIR Res Protoc. 2020 Sep 23;9(9):e20309 PMID: 32965223 PMCID: PMC7542405 SCOPUS ID: 2-s2.0-85092189788 09/24/2020
-
(Flynn KE, Mansfield SA, Smith AR, Gillespie BW, Bradley CS, Cella D, Helmuth ME, Lai HH, Kirkali Z, Talaty P, Griffith JW, Weinfurt KP, LURN Study Group.) Neurourol Urodyn. 2020 09;39(7):1939-1948 PMID: 32856723 SCOPUS ID: 2-s2.0-85088392697 08/29/2020
-
Designing a tablet-based prematurity education app for parents hospitalized for preterm birth.
(Rau NM, Hasan K, Ahamed SI, Asan O, Flynn KE, Basir MA.) Int J Med Inform. 2020 09;141:104200 PMID: 32563027 SCOPUS ID: 2-s2.0-85086509997 06/21/2020
-
Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
(Ernst A, Flynn KE, Weil EM, Crotty BH, Kamaraju S, Fergestrom N, Neuner J.) Clin Breast Cancer. 2020 Jul 22 PMID: 33183969 SCOPUS ID: 2-s2.0-85096389569 11/14/2020
-
Parental understanding of crucial medical jargon used in prenatal prematurity counseling.
(Rau NM, Basir MA, Flynn KE.) BMC Med Inform Decis Mak. 2020 07 22;20(1):169 PMID: 32698793 PMCID: PMC7376726 SCOPUS ID: 2-s2.0-85088443032 07/24/2020
-
Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial.
(D'Souza A, Szabo A, Flynn KE, Dhakal B, Chhabra S, Pasquini MC, Weihrauch D, Hari PN.) EClinicalMedicine. 2020 Jun;23:100361 PMID: 32529175 PMCID: PMC7280748 06/13/2020
-
(Cusatis RN, Tecca HR, D'Souza A, Shaw BE, Flynn KE.) Cancer. 2020 06 01;126(11):2679-2686 PMID: 32154926 PMCID: PMC7220834 SCOPUS ID: 2-s2.0-85081236553 03/11/2020
-
(Anguzu R, Cusatis R, Fergestrom N, Cooper A, Schoyer KD, Davis JB, Sandlow J, Flynn KE.) Hum Reprod. 2020 03 27;35(3):573-582 PMID: 32154565 PMCID: PMC7105327 SCOPUS ID: 2-s2.0-85082563377 03/11/2020
-
Designing a tablet-based prematurity education app for parents hospitalized for preterm birth
(Rau NM, Hasan K, Ahamed SI, Asan O, Flynn KE, Basir MA.) International Journal of Medical Informatics. September 2020;141 SCOPUS ID: 2-s2.0-85086509997 09/01/2020
-
Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial
(D'Souza A, Szabo A, Flynn KE, Dhakal B, Chhabra S, Pasquini MC, Weihrauch D, Hari PN.) EClinicalMedicine. June 2020;23 SCOPUS ID: 2-s2.0-85085967990 06/01/2020